Work

Reply to Francesco Barletta, Chiara Mercinelli, Francesco Montorsi, et al. re: Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer. Eur Urol 2026;89:550–551

Year: 2026

Type: letter

Source: European Urology

DOI: 10.1016/j.eururo.2026.04.032

Authors: Neal D. Shore, Stephen J. Freedland

Institutions: Carolina Urologic Research Center, Cedars-Sinai Medical Center, Durham VA Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Pfizer, Astellas Pharma

OpenAlex ID: W7168043596

Cites: 6

Cited by:

Related to: 10